RxDoctor Payments Data

Lane Cook, MD

Psychiatry · Knoxville, TNNPI 1174509590

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $38,713 of the $52,524 with a category attached, or 73.7%. Alkermes, Inc. accounts for 70.7% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $22,959 and has fallen 93.0% since, to $1,598 in 2025. Among psychiatry clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$52,524in general payments, 2019–2025

Across 528 payments — averaging $99.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$37K
  • Takeda Pharmaceuticals U.S.A., Inc.$6K
  • Teva Pharmaceuticals USA, Inc.$2K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Otsuka America Pharmaceutical, Inc.$1000
  • Neurocrine Biosciences, Inc.$964
  • plus $4K from 22 others

What the payments were for

  • Speaking & faculty fees$38,71374%
  • Travel & lodging$2,1534%
  • Food & beverage$11,21521%
  • Education$4421%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,524 in reported general payments places this provider in the 95th percentile of 503 psychiatry providers in Tennessee.

See all psychiatry providers in Tennessee

Medicare billing

Part B allowed, 2024
$75,781
Medicare patients
76
Services billed
549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine11$88,611
CaplytaLumateperone Tosylate25$44,248
VraylarCariprazine Hcl24$39,030
TrintellixVortioxetine Hydrobromide42$24,032
VyvanseLisdexamfetamine Dimesylate23$12,561
Lisdexamfetamine Dimesylate22$5,302
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine114$4,157
Duloxetine Hcl99$2,990
Desvenlafaxine Succinate ErDesvenlafaxine Succinate37$2,746
Bupropion XlBupropion Hcl79$2,119
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine45$1,914
Methylphenidate Hcl46$1,712
Trazodone Hcl135$1,686
Lurasidone Hcl14$1,482
Lamotrigine107$1,476

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$2,272$88,61111 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$1,193$44,24825 claims
AbbVieVraylar$415$39,03024 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$6,189$36,59365 claims
Almatica Pharma LLCSertraline Hcl$79$48362 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 503 psychiatry providers in Tennessee.

Other psychiatry in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →